The Biotech Growth Trust PLC (BIOG)
Market Closed
27 May, 10:52
LSE CBOE Primary LSE 1,312. 56
GBX +6.56
+0.5023%
- Market Cap
- Div Yield
1,852 Volume
1,306 GBX
Previous Close Want to track BIOG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
BIOG closed Wednesday higher at 1,312.56 GBX, an increase of 0.5023% from Tuesday's close, completing a monthly increase of 0% or 1,312.56 GBX. Over the past 12 months, BIOG stock gained 0%.
BIOG is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on CBOE (GBX).
BIOG Chart
The Biotech Growth Trust PLC (BIOG) FAQ
What is the stock price today?
The current price is 1,312.56 GBX.
On which exchange is it traded?
The Biotech Growth Trust PLC is listed on LSE.
What is its stock symbol?
The ticker symbol is BIOG.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has The Biotech Growth Trust PLC ever had a stock split?
No, there has never been a stock split.
The Biotech Growth Trust PLC Profile
| LSE Exchange | United States Country |
The Biotech Growth Trust PLC is a closed-ended investment company focused on the biotechnology sector. It seeks capital appreciation by investing in a diversified portfolio of shares and related securities from biotechnology companies worldwide, spanning regions such as the United States, Netherlands, Denmark, China, United Kingdom, France, and Canada. The trust maintains a concentrated portfolio of around 77 equity holdings, with the top 10 positions—including uniQure NV, Praxis Precision Medicines Inc, Ascendis Pharma AS ADR, and UroGen Pharma Ltd—accounting for approximately 40% of assets, all allocated to the healthcare sector. Managed with an ongoing charge of 1.20% and featuring 10% gross gearing, it benchmarks against the NASDAQ Biotechnology TR GBP index. Launched in 1997 and domiciled in the United Kingdom, The Biotech Growth Trust PLC trades openly and plays a key role in providing investors access to innovative biotech firms developing therapies in areas like precision medicine and therapeutics, contributing to the growth-oriented segment of global equity markets. With total assets around £289 million, it emphasizes long-term potential in this dynamic industry.
Contact Information
Address: 601 Lexington Avenue
Phone: 212-739-6400
